Impact of Exercise Training on Exercise Capacity in Patients With Severe Chronic Heart Failure
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients with heart failure are limited in their exercise capacity due to skeletal muscle alteration and an impairment of peripheral perfusion. Regular physical exercise training has been shown to partially correct these peripheral maladaptations in patients with stable heart failure, which was associated with an improvement in exercise capacity. However, it is unknown so far, whether regular physical activity also exerts beneficial effects in patients with severe chronic heart failure.
Aim of the trial is therefore to assess the effects of aerobic exercise training on exercise capacity, muscle maladaptations and peripheral perfusion in patients with severe chronic heart failure according to NYHA class III b.
| Condition | Intervention | Phase |
|---|---|---|
|
Heart Failure |
Behavioral: Aerobic endurance exercise training (ergometer) |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label |
| Official Title: | Impact of Three Months of Aerobic Exercise Training on Exercise Capacity and Peripheral Maladaptations in Patients With Severe Chronic Heart Failure (NYHA III b) |
- Peak oxygen uptake
- Endothelial function
- Skeletal muscle mass
- Markers of muscle anabolism / catabolism
| Estimated Enrollment: | 36 |
| Study Start Date: | March 2003 |
| Study Completion Date: | December 2006 |
A total of 36 patients with severe chronic heart failure are prospectively randomized to either 3 months of aerobic ergometer training or a sedentary control group.
Before and after the intervention period maximal exercise capacity is assessed by ergospirometry, endothelial function is determined by high-resolution A-mode ultrasound, and muscle mass is determined by CT. Skeletal muscle biopsies are obtained at begin and after 3 months and are analyzed for markers of muscle catabolism/anabolism.
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- chronic heart failure (NYHA class III b)
- peak oxygen uptake <20 mL/min/kg body weight
- left ventricular ejection fraction <25 %
- left ventricular end-diastolic diameter >60 mm
Exclusion Criteria:
- exercise-induced myocardial ischemia
- cardiac decompensation within the last 8 weeks
- ventricular arrhythmias (>Lown 4b) in patients not protected by an ICD
- insulin-dependent diabetes mellitus
- uncontrolled arterial hypertension
- orthopedic conditions excluding training participation
- body mass index >30 kg/m2
Contacts and Locations| Germany | |
| University of Leipzig, Heart Center, Department of Internal Medicine / Cardiology | |
| Leipzig, Saxony, Germany, 04289 | |
| Principal Investigator: | Rainer P Hambrecht, MD | University of Leipzig, Heart Center, Department of Internal Medicine / Cardiology, Leipzig, Germany |
More Information
No publications provided by University of Leipzig
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00176384 History of Changes |
| Other Study ID Numbers: | F21/02 |
| Study First Received: | September 10, 2005 |
| Last Updated: | July 31, 2007 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by University of Leipzig:
|
chronic heart failure exercise training |
Additional relevant MeSH terms:
|
Heart Failure Heart Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 21, 2013